This inventor holds 1 USPTO granted patent. Top assignee: Qilu Pharmaceutical Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovations of Peng Wan
Introduction
Peng Wan is a notable inventor based in Shandong, China. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on aflibercept compositions. His research and inventions have the potential to impact the quality control of aflibercept-containing products.
Latest Patents
Peng Wan holds a patent for a composition comprising aflibercept and a variant thereof. This patent, which includes a truncation variant with a truncated VEGF binding portion of aflibercept, is crucial for developing pharmaceutical formulations. The content of the truncation variant is specified to be less than or equal to about 20% by mass percentage. Additionally, the patent outlines methods for detecting the variant and its use in quality inspection or quality control of aflibercept-containing products. He has 1 patent to his name.
Career Highlights
Peng Wan is associated with Qilu Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work is instrumental in enhancing the efficacy and safety of pharmaceutical products.
Collaborations
He collaborates with esteemed colleagues such as Yue Yu and Guijiang Wang, contributing to a dynamic research environment that fosters innovation.
Conclusion
Peng Wan's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work not only advances scientific knowledge but also has practical applications in improving healthcare products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile